Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2012 | 34 | 5 |

Tytuł artykułu

Biotechnological approaches for cultivation and enhancement of secondary metabolites in Arnica montana L.

Warianty tytułu

Języki publikacji



Arnica montana L. (Asteraceae) is a valuable medicinal plant with anti-inflammatory and cicatrizing properties attributed to the sesquiterpene lactones, flavonoids and essential oil produced in the flower heads. In many European countries, the populations of A. montana are close to extinction in their natural habitats because of uncontrolled eradication and indiscriminate collection of the plants. Various approaches for in vitro propagation of the species and also, biosynthesis of secondary metabolites in tissue and cell cultures are assessed in the current review. Special attention is paid to the biological activity and chemical composition of compounds produced by the species as well as the opportunities of in vitro methods to isolate high-productive clones. The influence of different factors on the micropropagation, callusogenesis, genetic transformation and identification of certain biologically active substances is discussed in detail. By the reference to the available issues we concluded that biotechnology applied to A. montana cultivation may improved the plant preservation and increased the production of sesquiterpene lactones and other secondary metabolites.

Słowa kluczowe








Opis fizyczny



  • Institute of Plant Physiology and Genetics, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
  • Institute of Plant Physiology and Genetics, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria
  • Institute of Plant Physiology and Genetics, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria


  • Albert A, Sareedenchai V, Heller W, Seidlitz HK, Zidorn Ch (2009) Temperature is the key to altitudinal variation of phenolics in Arnica montana L. cv. ARBO. Oecologia 160(1):1–8. doi: 10.1007/s00442-009-1277-1
  • Assyov B, Petrova A, Dimitrov D, Vassilev R (ed) (2006) Conspectus of the Bulgarian vascular flora. Distribution maps and floristic elements. Bulgarian—Swiss Biodiversity Conservation Program, 2nd edn. BSBCP, Sofia, p 452
  • Bensaddek L, Villarreal ML, Fliniaux M (2008) Induction and growth of hairy roots for the production of medicinal compounds. Electron J Integr Biosci 3(1):2–9
  • Bezzi A, Ghidini G (1988) Preliminary trails on the cultivation of Arnica montana L. in the southern Alps and in the northern Apennines. Annali dell’Instituto Sperimentale per l’Assestamento Forestale e per l’Apicoltura 9:305–320
  • Bomme U (1993) Cultivation of Arnica montana is now possible. Bodenkultur und Pflanzenbau 5(13):3–11
  • Bomme U, Mittermeier M, Regenhardt I (1995) Results to develop a procedure for field-cultivation of Arnica montana L. 1 and 2. Mitteilung. Drogenreport 8(12):5–10
  • Bourgaud F, Gravot A, Milsei S, Gontier E (2001) Production of plant secondary metabolites: a historical perspective. Plant Sci 161:839–851. doi:10.1016/S0168-9452(01)00490-3
  • Butiuc-Keul AL, Deliu C (2001) Clonal propagation of Arnica montana L., a medicinal plant. In vitro Cell Dev Biol Plant 37:581–585. doi:10.1079/IVP2001222
  • Butiuc-Keul AL, Suteu A, Keul M, Deliu C (2002) The role of natural extract on the in vitro mulitiplication of Arnica montana L. Contrib Bot 37:183–189
  • Cassells AC, Walsh C, Belin M, Cambornac M, Robin JR, Lubrano C (1999) Establishment of a plantation from micropropagated Arnica chamissonis a pharmaceutical substitute for the endangered A. montana. Plant Cell Tiss Org 56(2):139–144. doi: 10.1023/A:1006224215503
  • Conchou O, Nichterlein K, Vömel A (1992) Shoot tip culture of Arnica montana for micropropagation. Planta Med 58(1):73–76. doi:10.1055/s-2006-961393
  • Daniel G, Bomme U (1991) Use of in vitro culture techniques in the breeding of Arnica (Arnica montana L.). Bayerisches Landwirtsch Jahrbuch 68:249–253
  • Delabays N, Mange N (1991) Culture of Arnica montana L.: the agronomy and plant protection. Rev Suisse Vitic Arboric Hortic 23(5):313–319
  • Douglas JA, Smallfield BM, Burgess EJ, Perry NB, Anderson RE, Douglas MH, Glennie VL (2004) Sesquiterpene lactones in Arnica montana: a rapid analytical method and the effects of flower maturity and simulated mechanical harvesting on quality and yield. Planta Med 70:166–170. doi:10.1055/s-2004-815495
  • Ellenberger A (1998) Assuming responsibility for a protected plant: WELEDA’s endeavor to secure the firm’s supply of Arnica montana. In: Proceedings of the first international symposium on the conservation of medicinal plants in trade in Europe. Royal Botanic Gardens, Kew, 22–23 June, pp 127–130
  • Evstatieva L (2008) Arnica chamissonis Less—a new medicinal plants for Bulgaria. In: 5th conference on medicinal and aromatic plants of Southeast European countries, Brno Czech Republic, pp 10–14
  • Flores HE, Medina-Bolivar F (1995) Root culture and plant natural products:’’unearthing’’ the hidden half of plant metabolism. Plant Tiss Cult Biotechnol 1:59–74
  • Galambosi B (2004) Introduction of Arnica montana L in Finland. Z Arzn Gew Pfl 9 Jg 4:174–179
  • Galambosi B, Sz-Galambosi Z, Svoboda KP, Deans SG (1998) Flower yield and antioxidant properties of Arnica montana L. grown in Finland. Drogenreport 11(19):10–13
  • Ganzera M, Egger C, Zidorn C, Stuppner H (2008) Quantitative analysis of flavonoids and phenolic acids in Arnica montana L. by micellar electrokinetic capillary chromatography. Anal Chim Acta 614:196–200. doi:10.1016/j.aca.2008.03.023
  • Garcia-Pineres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl H, Merfort I (2001) Cysteine 38 in p65/NF—kappa B plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 276:39713–39720. doi:10.1074/jbc.M101985200
  • Georgiev M, Pavlov AI, Bley T (2007) Hairy root type plant in vitro systems as sources of bioactive substances. Appl Microbiol Biotechnol 74(6):1175–1185. doi:10.1007/s00253-007-0856-5
  • Güntzel U, Seidel F, Kating H (1967) Studies on the contents of Arnica-species. I. Content on essential oil in the flowers of different Arnica-species. Planta Med 15(2):205–214. doi: 10.1055/s-0028-1099974
  • Iauk L, Lo Bue AM, Milazzo I, Rapisarda A, Blandino G (2003) Antibacterial activity of medicinal plant extracts against periodontopathic bacteria. Phytother Res 17(6):599–604. doi:10.1002/ptr. 1188
  • Judžentienė A, Būdienė J (2009) Analysis of the chemical composition of flower essential oils from Arnica montana of Lithuanian origin. Chemija 20:190–194
  • Kalynyak PP, Trofymyak TB, Komisarenko MF, Blyum YB (1995) Production of callus lines for plants from Arnica genus and analysis of their biosynthetic activity. Dopov Natsional Akad Nauk Ukrayiny 9:107–110 (in Ukraine)
  • Karuppusamy S (2009) A review on trends in production of secondary metabolites from higher plants by in vitro tissue, organ and cell cultures. J Med Plants Res 3(13):1222–1239
  • Kating H, Rinn W, Willuhn G (1970) Studies on the substance of species of Arnica. 3. Fatty acids in etheric oils of the flowers of various species of Arnica. Planta Med 18(2):130–146. doi: 10.1055/s-0028-1099758
  • Kennedy JF, Stevenson DL, White CA, Lombard A, Buffa M (1988) Analysis of the oligosaccharides from the roots of Arnica montana L., Artemisia absinthium L., and Artemisia dracuncula L. Carbohydr Polymers 9(4):277–285. doi:10.1016/0144-8617(88) 90046-X
  • Klass CA, Wagner G, Laufer S, Sosa S, Della Loggia R, Bomme U, Pahl HL, Merfort I (2002) Studies on the anti-inflammatory activity of phytopharmaceuticals prepared from Arnica flowers. Planta Med 68:385–391. doi:10.1055/s-2002-32067
  • Kohlmünzer S (ed) (2000) Farmakognozja. Pharmacognosy. Guide for pharmacy students. PZWL, Warszawa, p 669 (in Polish)
  • Kos O, Lindenmeyer MT, Tubaro A, Sosa S, Merfort I (2005) New sesquiterpene lactones from arnica tincture prepared from fresh flowerheads of Arnica montana. Planta Med 71:1044–1052. doi: 10.1055/s-2005-871284
  • Lange D (1998) Europe’s medicinal and aromatic plants: their use, trade and conservation. TRAFFIC International, Cambridge, pp 53–54
  • Lê CL (1994) In vitro multiplication of Arnica montana L. Revue Suisse de Viticulture, d’Arboriculture et d’Horticulture 26:391–395
  • Lê CL (1998) In vitro clonal multiplication of Arnica montana L. In: Proc. Plant Biotehnology as a tool for the exploitation of mountain lands, Turin, Italy, 25–27 May 1997. Acta Hortic 457:195–203
  • Lê CL (2000) Factors influencing the in vitro proliferation of Arnica montana L. In: COST 843, WG1: developmental biology of regeneration, Ist Meeting, 12–15 Oct 2000, Geisenheim, Germany, pp 29–30
  • Leven W, Willuhn G (1986) Spectrophotometric determination of sesquiterpenelactone S1 in Arnicae Flos Dab 9 with m-dinitrobenzene. Planta Med 52:537–538
  • Lopez-Anton N, Hermann C, Murillo R, Merfort I, Wanner G, Vollmar AM, Dirsch VM (2007) Sesquiterpene lactones induce distinct forms of cell death that modulate human monocytederived macrophage responses. Apoptosis 12:141–153. doi: 10.1007/s10495-006-0331-2
  • Lyss G, Schmidt TJ, Merfort I, Pahl HL (1997) Helenalin, an antiinflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappa-B. Biol Chem 378:951– 961. doi:10.1515/bchm.1997.378.9.951
  • Maguire B (1943) A monograph of the genus Arnica (Senecioneae, Compositae). Brittonia 4:386–510
  • Malarz J, Stojakowska A, Dohnal B, Kisiel W (1993) Helenalin acetate in in vitro propagated plants of Arnica montana. Planta Med 59(1):51–53. doi:10.1055/s-2006-959603
  • Merfort I (1992) Caffeoylquinic acids from flowers of Arnica montana and Arnica chamissonis. Phytochemistry (Oxford) 31:2111–2113. doi:10.1016/0031-9422(92)80373-M
  • Merfort I (2007) Arnika. New insights into an old medical plant. Internist Praxis 48(2):369–376
  • Merfort I, Wendisch D (1985) Flavonoids from Arnica montana and Arnica chamissonis Planta Med 51(2):136–138. doi:10.1055/s-2007-969428
  • Merfort I, Wendisch D (1987) Flavonoid glycosides from Arnica montana and Arnica chamissonis. Planta Med 53(5):434–437. doi:10.1055/s-2006-962766
  • Merfort I, Wendisch D (1988) Flavonoid glucuronides from the flowers of Arnica montana. Planta Med 54(3):247–250. doi: 10.1055/s-2006-962419
  • Merfort I, Wendisch D (1992) New flavonoid glycosides from Arnicae flos DAB 9. Planta Med 58(4):355–357. doi:10.1055/s-2006-961484
  • Mulabagal V, Tsay H (2004) Plant cell cultures—an alternative and efficient source for the production of biologically important secondary metabolites. Int J Appl Sci Eng 2:29–48
  • Nichterlein K (1995) Arnica montana (Mountain Arnica): in vitro culture and the production of sesquiterpene lactones and other metabolites. In: Bajaj YPS (ed) biotechnology in agriculture and forestry, medicinal and aromatic plants VIII, vol 33. Springer, Berlin, pp 47–61
  • Paßreiter CM, Willuhn G, Röder E (1992) Tussilagine and Isotussilagine: two pyrrolizidine alkaloids in the genus Arnica. Planta Med 58(6):556–557. doi:10.1055/s-2006-961549
  • Perry NB, Burgess EJ, Guitián MAR, Franco RR, Mosquera EL, Smallfield BM, Joyce NI, Littlejohn RP (2009) Sesquiterpene Lactones in Arnica montana: helenalin and dihydrohelenalin chemotypes in Spain. Planta Med 75(6):660–666. doi:10.1055/s-0029-1185362
  • Petriha RO, Masnuk YT (2008) Callusogenesis of Arnica montana L. in culture in vitro.Visnik National Univ 609:151–155
  • Petrova M, Tasheva K, Zagorska N, Evstatieva L (2005) In vitro propagation of Arnica montana L. CR Acad Bulg Sci 58(1): 67–72
  • Petrova M, Zayova E, Vlahova M (2008) Induction of callus cultures in Arnica montana L. Genet Breed 37(3–4):37–44
  • Petrova M, Zayova E, Yankova E, Baldzhiev G (2011) Plant regeneration from callus culture of Arnica montana. Rom Biotechnol Lett 16(1):92–97
  • Radanović D, Marcović T, Antić-Mladenović S, Pljevlakušić D, Ristić M, Krivokuća- Dokić D (2007) Yield and quality of Arnica (Arnica montana and Arnica chamissonis var. foliosa) cultivated in Serbia. In: 1st international scientific conference on medicinal, aromatic and spice plants. Nitra, Slovakia, pp 157–161
  • Ramachandra Rao S, Ravishankar GA (2002) Plant tissue cultures; chemical factories of secondary metabolites. Biotechnol Adv 20:101–153. doi:10.1016/S0734-9750(02)00007-1
  • Rey C (1984) First results on cultivation of medicinal and aromatic plants in Switzerland. Acta Hortic 144:183–191
  • Reyes-Salas O, Rangel-Ordoez L, Manzanilla-Cano JA, Barcel-Quintal MH, Dosal-Gmez MA (2002) Voltammetric determination of caffeic acid in Arnica Montana. Analytical Lett 35(6):971–984. doi:10.1081/AL-120004549
  • Rhodes MJC, Robins RJ, Hamill JD, Parr AJ, Hilton MG, Walton NJ (1990) Properties of transformed root cultures. In: Charlwood BV, Rhodes MJC (eds) Secondary products from plant tissue culture. Oxford University Press, Oxford, pp 201–225
  • Rossetti V, Lombard A, Sancin P, Buffa M, Di Stefano R (1984) Characterization of Arnica montana dried roots. Int J Crude Drug Res 22:53–60
  • Santer JO, Stevenson R (1962) Arnidiol and faradiol. J Org Chem 27:3204–3208
  • Santos MD, Almeida MC, Lopes NP, de Souza GE (2006) Evaluation of the anti-inflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull 29(11):2236–2240. doi:10.1248/bpb.29.2236
  • Schmidt TJ, Paßreiter CM, Wendisch D, Willuhn G (1992) First diterpens from Arnica. Planta Med 58(Suppl 1):A713
  • Schmidt TJ, Bomme U, Alfermann AW (1998) Sesquterpene lactone content in leaves of in vitro and field cultivated Arnica montana. Planta Med 64(3):268–270. doi:10.1055/s-2006-957423
  • Schmidt TJ, Stausberg S, von Raison J, Berner M, Willuhn G (2006) Lignans from Arnica species. Nat Prod Res 20:443–453. doi: 10.1080/14786410500218591
  • Schulte KE, Rücker G, Reithmayr K (1969) Certain constituents of Arnica chamissonis and other Arnica species. Lloydia 32(3): 360–368
  • Seeber H, Abraham H, Stupper H (1997) Culture experiments in South Tyrol with Arnica montana L. Drogenreport 10(16):10–16
  • Seemann A, Wallner T, Poschlod P, Heilmann J (2010) Variation of sesquiterpene lactone contents in different Arnica montana populations: influence of ecological parameters. Planta Med 76(8):837–842. doi:10.1055/s-0029-1240797
  • Spitaler R, Schlorhaufer PD, Ellmerer EP, Merfort I, Bortenschlager S, Stuppner H, Zidorn C (2006) Altitudinal variation of secondary metabolite profiles in flowering heads of Arnica montana cv. ARBO. Phytochemistry (Amsterdam) 67:409–417.doi:10.1016/j.phytochem.2005.11.018
  • Spitaler R, Winkler A, Lins I, Yanar S, Stuppner H, Zidorn CH (2008) Altitudinal variation of phenolic contents in flowering heads of Arnica montana cv. ARBO: a 3-year comparison. J Chem Ecol 34(3):369–375. doi:10.1007/s10886-007-9407-x
  • Stafford A (1991) Natural products and metabolites from plants and plant tissue cultures. In: Stafford A, Warren G (eds) Plant Cell Tiss Org, Open University Press, Buckingham, pp 124–162
  • Staneva J, Denkova P, Todorova M, Evstatieva L (2011) Quantitative analysis of sesqiuterpene lactones in extract of Arnica montana L. by 1HNMR spectroscopy. J Pharmaceut Biomed Anal.54:94–99. doi:org/10.1016/j.jpba.2010.08.018
  • Sugier D (2008) Trials with Arnica montana and Arnica chamissonis var. foliosa cultivation in Poland. In: 5th conference on medicinal and aromatic plants of southeast European countries (5th CMAPSEEC), Proceedings of scientific paper, 2-5.09.2008 Brno Czech Republic, pp 21–27
  • Tornhamre S, Schmidt TJ, Näsman-Glaser B, Ericsson I, Lindgren JA (2001) Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C(4) synthase in human blood cells. Biochem Pharmacol 62(7):903–911. doi:10.1016/S0006-2952(01),00729-8
  • Vanhaelen M (1973) Identification of carotenoids in Arnica Montana. Planta Med 23(4):308–311. doi:10.1055/s-0028-1099449
  • Wagner S, Merfort I (2007) Skin penetration behaviour of sesquiterpene lactones from different Arnica preparations using a validated GC-MSD method. J Pharm Biomed Anal 43:32–38. doi:10.1016/j.jpba.2006.06.008
  • Weremczuk-Jezyna I, Wysokiñska H (2000) Micropropagation of Arnica montana L. and sesquterpene lactones in regenerated plants. Biotechnologia 4:118–122
  • Weremczuk-Jeżyna I, Wysokińska H (2004) Culture of transformed roots of Arnica montana—isolation of secondary metabolites. Biotechnologia 2:54–60
  • Weremczuk-Jeżyna I, Kisiel W, Wysokińska H (2006) Thymol derivatives from hairy roots of Arnica montana. Plant Cell Rep 25(9):993–996. doi:10.1007/s00299-006-0157-y
  • Weremczuk-Jeżyna I, Kalemba D, Wysokińska H (2011) Constituents of the essential oil from hairy roots and plant roots of Arnica montana. J Essent Oil Res 23:91–97
  • White CA, Kennedy JF, Lombard A, Rossetti V (1985) Analysis of a homologous series of non-reducing oligosaccharides from Arnica montana L Roots. Brit Polym J 17:327–329. doi: 10.1002/pi.4980170401
  • Willuhn G (1972a) Studies on the contents of Arnica species. V. Content and variations in content of volatile oils in the various organs of Arnica species. Planta Med 21(3):221–245. doi:10.1055/s-0028-1099547
  • Willuhn G (1972b) Studies on the components of Arnica species. VI. Characterization and preparative separation of volatile oils from roots, rhizoma, leaves and flowerheads of various arnica species. Planta Med 21(4):329–342. doi:10.1055/s-0028-1099561
  • Willuhn G (1989) Arnikablüten In: Wichtl M (ed) Teedrogen und Phyto-pharmaka, 2nd edn. Wissenschaftliche Verlagsgesellschaft GmbH, Stuttgart, pp 65–69
  • Willuhn G (1991) Arnica montana L. Portrait of a medicinal plant Arnica montana L. Pharm Ztg 136:2453–2468
  • Willuhn G, Leven W (1991) On the qualitative and quantitative analysis of the sesquiterpene lactones from Arnica flowers DAB 9. Pharm Ztg Wiss 136(1):32–39
  • Willuhn G, Rottger PM, Matthiesen U (1983) Helenalin and 11,13-dihydrohelenalin esters from the flowers of Arnica montana. Planta Med 49(12):226–231. doi:10.1055/s-2007-969856
  • Willuhn G, Junior I, Wendisch D (1986) Desmethoxy-encecalin and thymolderivative from Arnica sachalinensis. Planta Med 5:349–351
  • Willuhn G, Leven W, Luley C (1994) Arnica flowers German Pharmacopeia 10 (DAB 10): investigation of the qualitative and quantitative variability of sesquiterpene lactone contents of official Arnica crude drugs. Dstch Apotheker Ztg 134:4077–4085
  • Winand C, Ramaut JL, Caspar T (1986) Multiplication vegetative par culture in vitro d’Arnica montana L. J Pharm Belg 41:147–150
  • Woerdenbag HJ, Merfort I, Passreiter CM, Schmidt TJ, Willuhn G, Van Uden W, Pras N, Kampinga HH, Konings AWT (1994) Cytotoxicity of flavonoids and sesquiterpene lactones from Arnica species against the GLC-4 and the COLO 320 cell lines. Planta Med 60:434–437. doi:10.1055/s-2006-959526
  • Wysokinska H, Chmiel A (2006) Secondary metabolites production in cultures of transformed plant organs. Biotechnologia 4:124–135
  • Willuhn G (1998) Arnica flowers: pharmacology, toxicology and analysis of the sesquiterpene lactones-their main active substances. In: Lawson L. D., Bauer R. (ed.): Phytomedicines of Europe, ACS Symp. Ser 691 Am. Chem. Soc. 691:118–132 doi: 10.1021/bk-1998-0691.ch010
  • Zapartan M, Deliu C (2001) Studies of in vitro regeneration and multiplication of Arnica montana L. (Asteraceae). Contrib Bot 36:131–135
  • Zayova E, Petrova M, Vitkova A, Yurukova P (2010) Effect of auxins on in vitro rhizogenesis and subsequent ex vitro acclimatization of Arnica montana. In: Biotechnology, Series F, Supplementary volume, Proceeding of the 3rd International Symposium ‘‘New Researches in Biotechnology’’ SimpBTH2010, pp 258–264


Rekord w opracowaniu

Typ dokumentu



Identyfikator YADDA

JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.